210 related articles for article (PubMed ID: 1772299)
1. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
Cilursu AM; Goeken J; Olson RR
Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities.
Kaufman LD; Varga J; Gomez-Reino JJ; Jimenez S; Targoff IN
Clin Immunol Immunopathol; 1995 Aug; 76(2):115-9. PubMed ID: 7542184
[TBL] [Abstract][Full Text] [Related]
4. [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].
Grangeia Tde A; Schweller M; Paschoal IA; Zambon L; Pereira MC
J Bras Pneumol; 2007; 33(6):747-51. PubMed ID: 18200378
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
Varga J; Maul GG; Jimenez SA
Arthritis Rheum; 1992 Jan; 35(1):106-9. PubMed ID: 1290474
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.
Kamb ML; Murphy JJ; Jones JL; Caston JC; Nederlof K; Horney LF; Swygert LA; Falk H; Kilbourne EM
JAMA; 1992 Jan; 267(1):77-82. PubMed ID: 1727200
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
Mizutani T; Mizutani H; Hashimoto K; Nakamura Y; Kishida M; Taniguchi H; Murata M; Kuzuhara S; Shimizu M
J Am Acad Dermatol; 1991 Sep; 25(3):512-7. PubMed ID: 1918490
[TBL] [Abstract][Full Text] [Related]
8. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
[TBL] [Abstract][Full Text] [Related]
9. [A case of the eosinophilia-myalgia syndrome].
Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
[TBL] [Abstract][Full Text] [Related]
10. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
Varga J; Uitto J; Jimenez SA
Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
[TBL] [Abstract][Full Text] [Related]
11. L-tryptophan and eosinophilia-myalgia syndrome.
Shapiro S
Lancet; 1994 Sep; 344(8925):817-9. PubMed ID: 7916094
[No Abstract] [Full Text] [Related]
12. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
[TBL] [Abstract][Full Text] [Related]
13. L-tryptophan and eosinophilia-myalgia syndrome.
Shapiro S
Lancet; 1994 Apr; 343(8904):1035-7. PubMed ID: 7909063
[No Abstract] [Full Text] [Related]
14. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM
Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958
[TBL] [Abstract][Full Text] [Related]
15. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome.
Johnson KL; Klarskov K; Benson LM; Williamson BL; Gleich GJ; Naylor S
J Rheumatol; 1999 Dec; 26(12):2714-7. PubMed ID: 10606395
[No Abstract] [Full Text] [Related]
16. L-tryptophan and the eosinophilia-myalgia syndrome.
Drug Ther Bull; 1990 May; 28(10):37-8. PubMed ID: 2131206
[No Abstract] [Full Text] [Related]
17. Gastrointestinal involvement in L-tryptophan (L-Trp) associated eosinophilia-myalgia syndrome (EMS).
De Schryver-Kecskemeti K; Bennert KW; Cooper GS; Yang P
Dig Dis Sci; 1992 May; 37(5):697-701. PubMed ID: 1563309
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
Daniels SR; Hudson JI; Horwitz RI
J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957
[TBL] [Abstract][Full Text] [Related]
19. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.
Allen JA; Peterson A; Sufit R; Hinchcliff ME; Mahoney JM; Wood TA; Miller FW; Whitfield ML; Varga J
Arthritis Rheum; 2011 Nov; 63(11):3633-9. PubMed ID: 21702023
[TBL] [Abstract][Full Text] [Related]
20. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
Bournerias I; Castot A
Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
